1. Home
  2. SCM vs SIGA Comparison

SCM vs SIGA Comparison

Compare SCM & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stellus Capital Investment Corporation

SCM

Stellus Capital Investment Corporation

HOLD

Current Price

$8.41

Market Cap

244.3M

Sector

Finance

ML Signal

HOLD

Logo SIGA Technologies Inc.

SIGA

SIGA Technologies Inc.

HOLD

Current Price

$3.05

Market Cap

223.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCM
SIGA
Founded
2012
1995
Country
United States
United States
Employees
N/A
49
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
244.3M
223.8M
IPO Year
2012
2016

Fundamental Metrics

Financial Performance
Metric
SCM
SIGA
Price
$8.41
$3.05
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$9.00
N/A
AVG Volume (30 Days)
286.6K
755.9K
Earning Date
05-11-2026
05-05-2026
Dividend Yield
14.22%
13.24%
EPS Growth
N/A
N/A
EPS
0.06
0.13
Revenue
N/A
N/A
Revenue This Year
$0.33
N/A
Revenue Next Year
N/A
$224.81
P/E Ratio
$141.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.83
$3.01
52 Week High
$14.85
$9.62

Technical Indicators

Market Signals
Indicator
SCM
SIGA
Relative Strength Index (RSI) 61.74 34.02
Support Level $7.93 $3.01
Resistance Level $8.59 $4.84
Average True Range (ATR) 0.35 0.17
MACD 0.16 0.01
Stochastic Oscillator 97.60 18.33

Price Performance

Historical Comparison
SCM
SIGA

About SCM Stellus Capital Investment Corporation

Stellus Capital Investment Corp is a closed-end, non-diversified management investment company. Its objective is to maximize the total return to its stockholders in the form of current income and capital appreciation. It invests in private middle-market companies through first lien, second lien, and unsecured debt financing, often with a corresponding equity investment. The company invests in various sectors, such as business services, energy, general industrial, government services, healthcare, software, and specialty finance. The business activity of the firm functions throughout the United States, and it generates revenue in the form of interest income on debt investments, capital gains, and distributions.

About SIGA SIGA Technologies Inc.

SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.

Share on Social Networks: